Objective.To estimate prevalence rates and analyze the quality and performance of Pap smears carried out on the Cervical Cancer Screening Program in Maringá, Paraná, Brazil. MethOds. A retrospective search was run on the Brazilian Ministry of Health SIS-Colo database. Variables such as age, cervical cytology result and district of residence were analyzed. Ages were divided into bands; residence was classified according to the five regional healthcare districts of the city of Maringá. Cervical cytology results were categorized according to the Bethesda System. Cervical screening coverage was calculated by dividing the number of tests within the population aged 25 to 59 by the number of women in that age range. Results. The 17.664 cervical cytology specimens collected during 2005 by the public health system were distributed across women aged from 12 to 82 years, with 12,961 (73.4%) of these tests being on women in the 25 to 59 range, who are considered at higher risk of cancer. A total of 17,458 (98.84%) cytological examinations were negative for malignancy, and there were 206 (1.16%) atypical results (ASCUS/AGUS, LSIL, HSIL and invasive cancer). The study found a prevalence of 0.85% (151) for ASCUS/AGUS and of 1.14% (203/17,664) for atypical cells, and a ASCUS/atypical cells ratio of 2.75 (151/55). cOnclusiOns. The lower than expected prevalence of abnormal cervical cytology results and low proportion of ASCUS, the elevated ASCUS/atypical cells ratio, the insufficient population coverage of that cervical cytology and the elevated cervical cancer mortality rate all compromise the performance of the cervical cancer prevention program. The population with low socioeconomic status need special attention and the more privileged must be better informed about the need for regular tests and which age group is at greatest risk.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.